Kyrgyzstan. Rosatom has started regular deliveries of technetium-99m generator kits to Kyrgyzstan. These will be supplied to the National Center of Oncology and Hematology in Bishkek. The GT-5K type generators produce technetium-99m, one of the most in-demand radionuclides in nuclear medicine. It is used in 80% of single-photon emission computed tomography (SPECT) diagnostic procedures for detecting oncological, cardiovascular, neuroendocrine, and other diseases. “Developing cooperation with the Kyrgyz Republic in the field of nuclear medicine is a step toward enhancing access to advanced technologies and timely diagnosis of various diseases,” said Maxim Kushnarev, CEO of V/O Izotop (part of Rosatom).